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Background: Depression is a common affliction for young adults, and is associated with a range of adverse
outcomes. Cognitive-reminiscence therapy is a brief, structured intervention that has been shown to be highly
effective for reducing depressive symptoms, yet to date has not been evaluated in young adult populations. Given
its basis in theory-guided reminiscence-based therapy, and incorporation of effective therapeutic techniques drawn
from cognitive therapy and problem-solving frameworks, it is hypothesized to be effective in treating depression in
this age group.
Methods and design: This article presents the design of a randomized controlled trial implemented in a
community-based youth mental health service to compare cognitive-reminiscence therapy with usual care for the
treatment of depressive symptoms in young adults. Participants in the cognitive-reminiscence group will receive six
sessions of weekly, individual psychotherapy, whilst participants in the usual-care group will receive support from
the youth mental health service according to usual procedures. A between-within repeated-measures design will
be used to evaluate changes in self-reported outcome measures of depressive symptoms, psychological wellbeing
and anxiety across baseline, three weeks into the intervention, post-intervention, one month post-intervention and
three months post-intervention. Interviews will also be conducted with participants from the cognitive-
reminiscence group to collect information about their experience receiving the intervention, and the process
underlying any changes that occur.
Discussion: This study will determine whether a therapeutic approach to depression that has been shown to be
effective in older adult populations is also effective for young adults. The expected outcome of this study is the
validation of a brief, evidence-based, manualized treatment for young adults with depressive symptoms.
Trial registration: Australian New Zealand Clinical Trials Registry ACTRN12613000084785.
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Depression is a prevalent mood disorder that is one of
the leading causes of disability worldwide [1]. Although
depression affects individuals across the adult lifespan,
onset typically occurs in adolescence or young adulthood
[2], with the average age of first episode around 25 years
[3,4]. The early onset of depressive symptoms, prior to
the age of 25, has also been found to be predictive of a
longer duration of symptoms, increased number of* Correspondence: david.hallford@deakin.edu.au
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distribution, and reproduction in any mediumdepressive episodes and higher frequency of suicide at-
tempts relative to later onset of depression (over 40 years
of age) [5]. In Australia, findings from the 2007 National
Survey of Mental Health and Wellbeing [6] indicated the
12-month prevalence of major depressive episodes to be
4.1%. However, for individuals aged 16 to 24, this preva-
lence was higher, at 6.3%. Furthermore, some evidence
suggests that this prevalence is increasing [7].
Psychological therapies for depression can provide
long-term positive outcomes for sufferers of depression
[8,9] and reduce the risk of further episodes [10-12].
However, a substantial number of individuals do notentral Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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[13], and expert working groups have recommended the
continued development or refinement of existing therap-
ies [14]. It is therefore clear that there exists an impera-
tive for the evaluation of new interventions for treating
depressive symptoms in young adults.
Reminiscence-based psychotherapies, which utilize the
purposeful review and analysis of autobiographical mem-
ories as a core component of therapy, have been shown
to be an evidence-based treatment approach for attenu-
ating depressive symptoms [15]. An extensive body of
research investigating the associations between memory
and depression indicates that reminiscence plays an im-
portant role in the maintenance of symptoms. Compared
with those who are not depressed, clinically depressed
individuals remember relatively more emotionally nega-
tive events [16] and use a more depressive explanatory
style when recalling life narratives [17]. Depressed indi-
viduals also exhibit a tendency for overgeneralization
when recalling memories, and this can impair their abil-
ity to cope with stressors through problem solving and
reduce their ability to use memories to predict future
events rationally and accurately. Furthermore, it is pre-
dictive of more severe depressive symptoms and delayed
recovery [18,19].
Meta-analyses of evaluations of reminiscence-based
therapies [15,20] have shown significant effects for these
approaches in reducing depressive symptoms. Those
reminiscence-based therapies that incorporate other
therapeutic frameworks for conceptualizing and treating
depression have been particularly compelling. Of these,
cognitive-reminiscence therapy has demonstrated per-
haps the most promising outcomes, with consistently
large pre-post-treatment effect sizes [21-23] and high
patient-reported satisfaction [23]. Cognitive-reminis-
cence therapy incorporates structured and guided rem-
iniscence utilizing a Beckian cognitive therapy model of
depression treatment [24,25] and a stress and coping
model of depression [26,27] with problem-solving tech-
niques [28]. Although this treatment has only been eval-
uated with older adults, it has been argued that it may
also be appropriate and effective in young adult popula-
tions [29].
In cognitive-reminiscence therapy, therapists assist in-
dividuals in reviewing events and experiences from their
life whilst using established therapeutic techniques from
the frameworks discussed previously to restructure nega-
tive and dysfunctional beliefs, positively reframe and re-
story narratives, and build self-efficacy and coping skills.
It is proposed that this approach works through several
specific mechanisms to treat depression. Firstly, increas-
ing autobiographical memory specificity can disrupt
depressed individuals’ tendency to use overgeneral
and negatively-valanced memories. Indeed, results fromseveral recent trials have shown that simply eliciting spe-
cific autobiographical memories in a concerted manner
can decrease depressive symptoms [30,31] and increase
problem-solving skills [32]. Secondly, the cognitive
therapy techniques employed when reviewing past mem-
ories, such as psychological distancing and adaptively
restructuring beliefs, have been shown to underpin re-
ductions in depressive symptoms [33,34]. Thirdly, the
problem-solving techniques that are used to highlight
past coping ability, build a sense of resilience and formu-
late new solutions to current challenges, have been
shown to be effective for treating depression [28], and
specifically for young adults [35].
Previous trials of cognitive-reminiscence therapy have
examined its effects in a group-based format, typically
with two to four individuals [21-23]. Little is currently
known though about the effect of this intervention in a
one-to-one, individual therapy format. Relative to group
therapy, an individual format for treatment would con-
ceivably allow the therapist and client additional time
within sessions to examine and reinterpret events and
experiences from the past more fully, to form a more
positive life narrative. Research generally supports the
notion that individual therapy is more effective than
group therapy in the treatment of depression [36,37];
however, this premise has yet to be tested in the case of
cognitive-reminiscence therapy.
In summary, cognitive-reminiscence therapy has been
shown to be a highly effective intervention for depressive
symptoms that has not been evaluated with young adults
to date. Our trial will aim to rectify this gap in the clin-
ical research literature by implementing a randomized,
controlled trial to provide evidence of its effectiveness
relative to usual care in a community-based youth men-
tal health service. The trial was designed to address two
questions. Firstly, is cognitive-reminiscence therapy
effective in reducing depressive symptoms in young
adults? And secondly, how effective is cognitive-
reminiscence therapy in comparison with usual care at a
youth mental health service?Methods and design
Study design
To evaluate the effectiveness of cognitive-reminiscence
therapy in the treatment of young adults with depressive
symptoms, we will conduct a randomized controlled trial
and compare this intervention with usual care. We will
utilize a between-within, repeated-measures design over
five time-points (baseline, three weeks into the interven-
tion, post-intervention, one month post-intervention,
and three months post-intervention) to assess for both
within-group change and differences between these
groups in change.
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Young adults will be recruited from a community youth
mental health service in the city of Melbourne, Australia.
As the eligible age of intake at these participating ser-
vices is capped at 25 years of age, it is not anticipated
that any individuals will exceed this age range. The in-
clusion and exclusion criteria for participation will be:
1. 18 years of age, or older.
2. The presence of at least moderate depressive
symptoms, as indicated by a score of seven or higher
on the DASS-21 depression subscale [38].
3. Not currently receiving any other treatment for
depression.
4. Depressive symptoms are not the product of
physical causes (for example, hypothyroidism).
5. Not at high risk of suicide or harm to others
(as assessed through intake interviews).
6. Not presenting with a primary problem related to
psychotic symptoms, disordered eating, manic
symptoms, body image disturbance, anxiety,
substance use or sexual dysfunction.
Individuals will only be excluded from participating in
the study in the case that problems other than depres-
sion are the primary reason for presentation (as assessed
at intake), or other problems emerge as the primary rea-
son for help-seeking during treatment and therefore
supersede depressive symptoms as the likely target for
therapy (as assessed during the course of the study).
Procedure
Initially, intake clinicians working at the youth mental
services will identify individuals eligible to participate in
the study through assessments conducted as part of their
normal triage protocol. This includes a structured face-
to-face assessment of psychosocial and mental health
problems, which provides the information necessary to
determine eligibility based on the criteria listed [39]. The
study will be introduced to eligible individuals, who will
then be screened for the presence of at least moderate
depressive symptoms using the DASS-21 depression
subscale [38] and provided with the plain language state-
ment. Permission for a member of the research team to
contact them will be sought. A member of the research
team will then contact them to discuss the details of the
study further and answer any questions they may have.
If the individuals agree to participate, informed consent
will be sought and participants will be randomized into
one of the treatment conditions.
Randomization
Participants will be randomized to conditions using an
adaptive biased-coin approach, the ‘urn design’ [40]. Inan urn design, the probability of assignment to a group
begins at 1:1, and is subsequently based on the magni-
tude of imbalance between groups. If the allocation ratio
is found to be too far in one group’s favour then the
probability is altered to increase the odds of allocation
to the smaller group until this imbalance is rectified.
This approach was chosen so as to counteract the risk of
unequal group sizes, whilst still preserving most of the
unpredictability of simple randomization. Randomiza-
tion will be performed by a third-party outside of the
research team using the online software Research
Randomizer Version 3.0 [41].
Sample size
Sample size was calculated using GPower 3 [42], with
two aims of the current study under consideration:
whether participants in the cognitive-reminiscence ther-
apy group report improvements on measures over time,
and whether these effects differ from those achieved by
usual care. Although previous evaluations of this inter-
vention with older adults have produced large effect
sizes; [21-23], it was decided to err on a somewhat more
conservative side and estimate a sample size for a
moderate-to-large within-group effect over time. It was
calculated that using a repeated-measures within-subject
analysis of variance (ANOVA) across five time-points
with an α level set at 0.05 (two-tailed), statistical power
level (1 − β) of 0.80, and an estimate of correlation
among repeated measures of 0.5, 15 participants will be
needed in the cognitive-reminiscence group to detect
this effect. To assess for a small-to-moderate interaction
effect between groups and time using the parameters de-
scribed above, a total of 32 participants (16 per group)
will be needed. After factoring in the average dropout
rate of 20% for reminiscence-based therapies [20], it is
estimated that a minimum of 19 participants per group
(total N = 38) will need to be recruited to assess within-
group effects and differences between groups in treat-
ment effects.
Conditions
Cognitive-reminiscence
Participants in this group will receive an intervention
based on a manualized reminiscence therapy formulated
by Watt and Cappeliez [21]. Although the intervention
will follow the general protocol of this manual, several
distinct adaptations will be made for the current study.
Firstly, the original manual described separate but over-
lapping protocols for integrative and instrumental rem-
iniscence therapy. The current intervention will combine
these two approaches, as per Cappeliez [23]. Secondly,
the content of the sessions will be organized on the basis
of only one participant, rather than a group delivery, for
which it was originally designed. Thirdly, the questions
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ories will be age-appropriate for young adults and their
stage of psychosocial development.
The intervention will be administered on the premises
of the participating youth mental health service. The
intervention comprises six 60-minute weekly sessions of
individual psychotherapy. Over the course of therapy, six
different topics are used to stimulate memories as a
basis for therapeutic work. These are: turning points,
family life, major life works, loves and hates, stressful
experiences, and meaning in life. In the first session,
rapport is built and psychoeducation is provided on
autobiographical memory (specifically, integrative and
instrumental types of reminiscence), related depresso-
genic patterns, and cognitive therapy and stress and cop-
ing models of depression. Information is provided about
the intervention, including evidence for its effectiveness
and what it entails for the participant and therapist. Fol-
lowing this, the first topic, turning points, is discussed,
using a list of questions to help stimulate memories. The
procedure for therapeutic work then follows the same
pattern in each session. Memories are elicited and
among these several are identified by the therapist and
participant collaboratively as being of importance and to
be discussed. The therapist ensures that there is at least
one event or experience that is likely to benefit from
cognitive therapy techniques and one that relates to
stress and coping. These memories are then elaborated
on, with the therapist ensuring that sufficient details of
the memories are provided so as to promote increases in
memory specificity. The respective therapeutic tech-
niques are then utilized where appropriate, for example,
restructuring beliefs about perceived failures and nega-
tive experiences, focusing on positive experiences and
achievements to enhance perceptions of self-worth or
self-efficacy, and breaking down previous coping step-
by-step and highlighting effective strategies. As a general
guideline, the therapist aims to help the individual create
a cohesive and positive narrative of their life and a view
of themselves that realistically integrates good and bad
experiences. Further, therapists orient themselves to-
wards improving clients’ perceptions of their meaning in
life, self-esteem, self-efficacy, and optimism, given that
these variables have been shown to mediate adaptive
reminiscence functions and depressive symptoms [43]
and changes produced by reminiscence-based therapies
[44,45]. In the first session, a brief problem-solving
framework is introduced, and a problem list is elicited
for work in subsequent sessions. At the end of the ses-
sion, a summary is provided and feedback is elicited
from the participant on what was learned and any
changes that have occurred. A homework sheet is then
provided, listing questions related to the next week’s
topic. A rationale is provided for this homework sheet,including its usefulness in promoting effective change
[46]. The following five sessions follow a similar proced-
ure of reviewing homework on the topic for the week,
identifying memories to elaborate on and engaging in
therapeutic work with these memories, and utilizing a
problem-solving framework to choose solutions to iden-
tified problems to implement over the next week. Spe-
cific coping strategies that have been discussed in the
session are drawn on to assist in the problem-solving
work, as well as content related to self-efficacy and
approach-coping behaviour that is broadly promoted
over the sessions. In the last session, a summary is pro-
vided by the therapist of the work completed over the
intervention, and the participant is invited to provide
feedback of the experience and reflect on any change
that has occurred.
Following the completion of the sixth session of ther-
apy, participants will be free to utilize any further
services or support that they wish. To ensure adherence
to the treatment protocol, the treating therapist will
complete a brief checklist following each session, noting
whether required components of the therapy were cov-
ered in each session.
Usual care
Participants in the usual-care condition will receive sup-
port following the normal procedures implemented by
the clinical pathway coordinator of the participating
youth mental health service. There will be no restriction
on the type, amount or length of support that is re-
ceived. Given the service in which the study will be
conducted, this support will probably consist of six to
ten sessions of evidence-based psychological treatment
provided by registered mental health professionals. In-
formation will be collected for each participant on what
their usual care constitutes so that it can be described as
a group and contrasted with the cognitive-reminiscence
group. Following the cessation of data collection, all
participants in the usual-care group will be invited to
receive the six-week course of cognitive-reminiscence
therapy should they wish.
Outcome measures
All outcome measures will be completed online via links
that are emailed to participants at the relevant time-
points. As stated, the time-points will be baseline, three
weeks into the intervention, post-intervention, one month
post-intervention, and three months post-intervention.
Multiple time-points will be used to increase statistical
power [47], improve the chance of detecting when signifi-
cant change occurs, and examine whether treatment
effects are maintained following the end of treatment. The
demographic information that will be collected from par-
ticipants will be: age, sex, education, employment status,
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for depression has been received.
Primary outcomes
The primary outcome will be depressive symptomatol-
ogy. To assess for depressive symptoms the seven-item
self-report depression subscale from the short-form De-
pression, Anxiety, and Stress Scale (DASS-21 [38]) will
be used. Each item is rated on a four-point scale from 0
(did not apply to me at all) to 3 (applied to me very
much, or most of the time). The DASS-21 is a valid and
reliable method of assessing core depressive symptom-
atology (low positive-affect, anhedonia, lack of motiv-
ation, low self-esteem and hopelessness), possesses good
psychometric properties [48], and has been validated for
use with young adults [49].
Secondary outcome measures
Recent meta-analytic results have indicated improve-
ments across a number of domains of psychological
wellbeing as a result of reminiscence-based therapy [15].
To assess the generalizability of these changes to young
adults some of these will be used as secondary outcome
variables. Across the following measures, participants
will respond to 11-point, end-defined scales. Meaning in
life will be measured using the presence subscale of the
Meaning in Life Questionnaire [49], which comprises
five items and has good psychometric properties [50].
Higher scores indicate a stronger sense of personal
meaning. Self-efficacy will be measured using the eight-
item New General Self-Efficacy Scale [51]. This scale
measures general perceived competence underlying task
or domain-specific self-efficacy using eight items,
whereby higher scores indicate a stronger sense of gen-
eral self-efficacy. The New General Self-Efficacy Scale is
psychometrically strong, and has demonstrated superior-
ity over other measures of general self-efficacy [52]. Self-
esteem will be measured using a short-form, five-item
version of the Rosenberg Self-Esteem Scale [53]. This
short-form version has good internal reliability [42], and
retains the measurement fidelity of the full scale [54].
Higher scores on this scale indicate higher levels of per-
ceived self-worth.
Two additional secondary outcome measures will be
assessed. Firstly, given the therapeutic aims of this inter-
vention, it is reasoned that increases in optimism and
positive future-orientation may be possible outcomes.
To assess for this, a short-form, three-item version of
the Life Orientation Test – Revised [55], consisting of
the three positively worded items will be used. This test
has demonstrated good psychometric properties [55],
with high internal reliability also reported for the
short-form version [43]. Higher scores on this scale indi-
cate more positive generalized outcome expectancies.Secondly, as some previous trials of reminiscence-based
therapies have also been shown to produce significant
reductions in anxiety symptoms [56,57], this will also be
assessed. The anxiety subscale on the DASS-21, which
measures core symptoms of autonomic arousal, will be
used to assess anxiety. The anxiety subscale of the
DASS-21 shares the same scale design as the depression
subscale, and also its sound psychometric properties.
Qualitative data
In addition to collecting demographics and outcome
measures, one-to-one interviews with participants from
the cognitive-reminiscence condition will also be con-
ducted following completion of the final session of ther-
apy. As the use of a reminiscence-based therapy is some-
what novel in young adult populations, the addition of
qualitative data will provide richer, more detailed infor-
mation regarding participants’ phenomenological ac-
count of the intervention. A semistructured interview
schedule will be used to collect in-depth information on
participants’ experiences. Open-ended questions with in-
ductive probing will be used to answer research ques-
tions, such as what participants’ experience of the
intervention was like, how they perceived the main task
of discussing past events and experiences in their lives,
which aspects they found helpful or unhelpful, whether
the intervention produced any changes for them, their
attitude towards the length of the intervention, and what
they might like to see included that was not. To reduce
the potential for bias, the interviews will be conducted
by a researcher outside of the research team responsible
for the trial. Interviews will be conducted with partici-
pants until data saturation is reached, or all willing par-
ticipants have been interviewed.
Analysis
Baseline characteristics (demographic, clinical and well-
being variables) will be compared using chi-square ana-
lyses for categorical variables and t tests for continuous
variables. For the primary and secondary outcomes,
repeated-measures ANOVAs will be conducted, along
with appropriate post-hoc analyses. Effect sizes will be
calculated using Cohen’s d, which is based on the pooled
standard deviation, along with 95% confidence intervals.
To assess individuals for clinically significant change on
the primary outcome and distinguish between improved,
unchanged and deteriorated cases, the reliable change
index will be used [58]. Analyses will be conducted on
post-treatment data using intention-to-treat methods
presented in the CONSORT guidelines [59], with appro-
priate imputation of missing data. Qualitative data will
be analyzed using applied thematic analysis techniques
[60]. Interviews will be transcribed, coded and grouped
into themes using an iterative process, and then the
Hallford and Mellor Trials 2013, 14:343 Page 6 of 8
http://www.trialsjournal.com/content/14/1/343themes will be refined and interpreted. Quantitative data
reduction techniques will also be used to analyze the fre-
quency of particular attitudes and agreement or dis-
agreement with specific questions, such as whether
participants thought the intervention was long enough.
Consent and ethics
All participating young adults will be provided with a plain
language statement, and receive a verbal explanation of its
contents along with assistance in answering any questions
they might have. They will then provide written informed
consent to participate in the study. The project has been
approved by the Deakin University Human Research
Ethics Committee (DU-HREC 2012–278).
Discussion
Depression is a prevalent problem for young adults, and
is associated with a range of adverse outcomes, including
impairments in social, occupational and physical func-
tioning [61], increased experience of pain [62], and
higher rates of mortality caused by an increased risk of
suicide and physiological changes, such as immunosup-
pression that increase susceptibility to death [63]. The
high economic burden of depression has been noted
across a large number of studies [64] and is predomin-
ately related to such factors as loss of work productivity,
increased cost of healthcare and specialist treatment
[64,65]. Given this, as well as the fact that nonre-
sponders to treatment are found across all treatment
modalities and therefore no one treatment for depres-
sion is useful for all, further development of brief, effect-
ive treatments is justified.
This trial will help to evaluate a therapy among young
adults that has a demonstrated record of large, clinically
significant effects on depression in older adults. Given
that young adults, relative to older adults, have a higher
reported use of reminiscence for identity cohesion and
clarity [66], and draw on the past to assist in task-based
behaviour and clarify future goals [67], therapies such as
cognitive-reminiscence therapy may be highly relevant
for them. Quantitative and qualitative data gathered
through this study will also help elucidate how and why
this type of intervention might be helpful for young
adults. These findings will assist in identifying changes
that may need to be made to help further refine this
therapy, and increase its specificity.
Despite the new findings that this trial is likely to gen-
erate, several limitations may be forecast. Perhaps most
importantly, the small sample size of this trial is likely to
limit the generalizability of the findings, and to limit the
opportunity to identify moderating variables. However,
as no pilot studies in this age group exist, and therefore
the effectiveness of this therapy with young adults is
largely unknown, a larger trial and the resourcesnecessary to conduct it could not be justified at this
stage. Depending on the outcomes of this trial, future re-
search may look to utilize a larger sample. There is a
chance that young adults will not respond well to this
retrospectively oriented treatment modality, although no
reliable evidence currently exists to support this conten-
tion, and a reasoned argument to the contrary has been
constructed based on developmental and cognitive-
based research [29].
In summary, the expected outcomes of this study are
the validation of a manualized, therapeutic approach to
treatment of depression in young adults, and new data
concerning young adults’ experience of receiving this
intervention and changes relating to broader psycho-
logical wellbeing that may occur. This manualized psy-
chotherapy may then be implemented in mental health
services to address the needs of young adults presenting
with depressive symptoms.
Trial status
Recruitment for the trial began in January 2013.
Abbreviations
ANOVA: Analysis of variance; DASS: Depression, Anxiety, and Stress Scale.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
DJH and DM conceived the project. DH produced the first and subsequent
drafts of this paper, which DM reviewed. Both authors read and approved
the final manuscript.
Acknowledgements
No funding was received for the project. This work was made possible with
the assistance of headspace National Youth Mental Health Foundation and
the Youth Support and Advocacy Service.
Received: 3 June 2013 Accepted: 2 October 2013
Published: 21 October 2013
References
1. World Health Organization: Depression. [http://www.who.int/mediacentre/
factsheets/fs369/en/index.html]
2. Kessler RC, Chiu WT, Demler O, Walters EE: Prevalence, severity, and
comorbidity of 12-month DSM-IV disorders in the National Comorbidity
Survey Replication. Arch Gen Psychiatry 2005, 62:617–627.
3. González HM, Tarraf W, Withfield KE, Vega WA: The epidemiology of major
depression and ethnicity in the United States. J Psychiatr Res 2010,
44:1043–1051.
4. Jacobi F, Wittchen HU, Hölting C, Höfler M, Pfister H, Müller N, Lieb R:
Prevalence, co-morbidity and correlates of mental disorders in the
general population: results from the German Health Interview and
Examination Survey (GHS). Psychol Med 2004, 34:597–611.
5. Korten NCM, Comijs HC, Lamers F, Penninx BWJH: Early and late onset
depression in young and middle aged adults: differential symptomatology,
characteristics and risk factors? J Affect Disord 2012, 138:259–267.
6. Slade T, Johnston A, Browne MAO, Andrews G, Whiteford H: National
survey of mental health and wellbeing: methods and key findings.
Aust NZ J Psychiatry 2007, 2009(43):594–605.
7. Goldney RD, Eckert KA, Hawthorne G, Taylor AW: Changes in the
prevalence of major depression in an Australian community sample
between 1998 and 2008. Aust NZ J Psychiatry 2010, 44:901–910.
Hallford and Mellor Trials 2013, 14:343 Page 7 of 8
http://www.trialsjournal.com/content/14/1/3438. Bockting CLH, Spinhoven P, Wouters LF, Koeter MWJ, Schene AH: Long-
term effects of preventative cognitive therapy in recurrent depression: a
5.5-year follow-up study. J Clin Psychology 2009, 70:1–8.
9. Kupfer DJ, Frank E, Perel JM: The advantage of early treatment intervention
in recurrent depression. Arch Gen Psychiatry 1989, 46:771–775.
10. Hollon SD, DeRubeis RJ, Shelton RC, Amsterdam JD, Salomon RM,
O’Reardon JP, Lovett ML, Young PR, Haman KL, Freeman BB, Gallop R:
Prevention of relapse following cognitive therapy vs medications in
moderate to severe depression. Arch Gen Psychiatry 2005, 62:417–422.
11. Paykel ES: Cognitive therapy in relapse prevention in depression.
Int J Neuropsychopharmacology 2007, 10:131–136.
12. Vittengl JR, Clark LA, Dunn TW, Jarrett RB: Reducing relapse and recurrence in
unipolar depression: a comparative meta-analysis of cognitive-behavioral
therapy’s effect. J Consult Clin Psychol 2007, 75:475–488.
13. Hollon SD, Thase ME, Markowitz JC: Treatment and prevention of
depression. Psychol Sc Pub Interest 2002, 3:39–77.
14. Hollon SD, Muñoz RF, Barlow DH, Beardslee WR, Bell CC, Bernal G, Clarke
GN, Franciosi LP, Kazdin AE, Kohn L, Linehan MM, Markowitz JC, Miklowitz
DJ, Persons JB, Niederehe G, Sommers D: Psychosocial intervention
development for the prevention and treatment of depression:
promoting innovation and increasing access. Biol Psychiatry 2002,
52:610–630.
15. Pinquart M, Forstmeier S: Effects of reminiscence interventions on
psychosocial outcomes: a meta-analysis. Aging Ment Health 2012,
16:541–558.
16. Fromholt P, Larsen P, Larsen SF: Effects of late-onset depression and
recovery of autobiographical memories. J Gerontol 1995, 50:74–81.
17. Habermas T, Ott LM, Schubert M, Schneider B, Pate A: Stuck in the past:
negative bias, explanatory style, temporal order, and evaluative
perspectives in life narratives of clinically depressed individuals.
Depress Anxiety 2008, 25:121–132.
18. Sumner JA, Griffith JW, Mineka S: Overgeneral autobiographical memory
as a predictor of the course of depression: a meta-analysis. Behav Res
Ther 2010, 48:614–625.
19. Willams JMG, Barnhofer T, Crane C, Hermans D, Raes F, Watkins E, Dalgeish
T: Autobiographical memory specificity and emotional disorder. Psychol
Bull 2007, 133:122–148.
20. Bohlmeijer ET, Smit F, Cuijpers P: Effects of reminiscence and life review
on late-life depression: a meta-analysis. Int J Geriat Psychiatry 2003,
18:1088–1094.
21. Watt LM, Cappeliez P: Integrative and instrumental reminiscence
therapies for depression in older adults. Intervention strategies and
treatment effectiveness. Aging Ment Health 2000, 4:166–177.
22. Karimi H, Dolatshahee B, Momeni K, Khodabakhasi A, Rezaei M, Kamrani AA:
Effectiveness of integrative and instrumental reminiscence therapies on
depressive symptom reduction in institutionalised older adults: an
empirical study. Aging Ment Health 2010, 14:881–887.
23. Cappeliez P: Cognitive-reminiscence therapy for depressed older adults
in day hospital and long-term care. In Critical Advances in Reminiscence
Work: From Theory to Application. Edited by Webster JD, Haight BK. New
York: Springer; 2002:300–313.
24. Beck AT: Cognitive Therapy and the Emotional Disorders. New York,
NY: International Universities Press; 1976.
25. Beck AT, Rush AJ, Shaw BF, Emery G: Cognitive Therapy of Depression.
New York, NY: Guildford Press; 1979.
26. Billings AG, Moos RH: Psychosocial theory and research on depression: an
integrative framework and review. Clin Psychol Rev 1982, 2:213–237.
27. Billings AG, Moos RH: Psychosocial stressors, coping and depression. In
Handbook of Depression: Treatment, Assessment, and Research. Edited by
Beckman EE, Leber WR. Homewood, IL: Dorsey Press; 1985:940–974.
28. Nezu AM: Problem-solving and behaviour therapy revisited. Beh Ther
2004, 35:1–33.
29. Hallford DJ, Mellor D: Reminiscence-based therapies for depression:
should they be used only with older adults? Clin Psychol Sci Pract. in press.
30. Neshat-Doost HT, Dalgleish T, Yule W, Kalantari M, Ahmadi SJ, Dyregrov A,
Jobson L: Enhancing autobiographical memory specificity through
cognitive training an intervention for depression translated from basic
science. Clin Psychol Sci 2013, 1:84–92.
31. Serrano JP, Latorre JM, Gatz M, Montanes J: Life review therapy using
autobiographical retrieval practice for older adults with depressive
symptomatology. Psychol Aging 2004, 19:272–277.32. Raes F, Williams JMG, Hermans D: Reducing cognitive vulnerability to
depression: a preliminary investigation of MEmory Specificity Training
(MEST) in inpatients with depressive symptomatology. J Behav Ther Exp
Psychiatry 2009, 40:24–38.
33. Garratt G, Ingram RE, Rand KL, Sawalani G: Cognitive processes in
cognitive therapy: evaluation of the mechanisms of change in the
treatment of depression. Clin Psychol Sci Pract 2009, 14:224–239.
34. Quilty LC, McBride C, Bagby RM: Evidence for the cognitive mediational
model of cognitive behavioural therapy for depression. Psychol Med 2009,
38:1531–1541.
35. Eskin M, Ertekin K, Demir H: Efficacy of a problem-solving therapy for
depression and suicide potential in adolescents and young adults.
Cog Ther Res 2008, 32:227–245.
36. Cuijpers P, van Straten A, Warmerdam L: Are individual and group
treatments equally effective in the treatment of depression in adults? A
meta-analysis. Euro J Psychiatry 2008, 22:38–51.
37. McDermut W, Miller IW, Brown RA: The efficacy of group psychotherapy
for depression: a meta-analysis and review of the empirical research.
Clin Psychol Sci Pract 2001, 8:98–116.
38. Lovibond PF, Lovibond SH: Manual for the Depression Anxiety Stress Scales.
2nd edition. Sydney, Australia: Psychology Foundation of Australia; 1995.
39. Parker AG, Hetrick SE, Purcell R: Assessment of mental health and
substance use disorders in young people: refining and evaluating a
youth-friendly assessment interview. Aust Fam Physician 2010,
39:585–588.
40. Wei LJ, Lachin JM: Properties of the urn randomization in clinical trials.
Control Clin Trials 1988, 9:345–364.
41. Urbaniak GC, Plous S: Research Randomizer (version 3.0). [http://www.
randomizer.org]
42. Faul F, Erdfelder E, Lang AG, Buchner A: G*Power 3: a flexible statistical
power analysis program for the social, behavioral, and biomedical
sciences. Behav Res Methods 2007, 39:175–191.
43. Hallford DJ, Mellor D, Cummins RA: Adaptive autobiographical memory in
younger and older adults: the indirect association of integrative and
instrumental reminiscence with depressive symptoms. Memory 2012,
21:444–457.
44. Korte J, Westerhof GJ, Bohlmeijer ET: Mediating processes in an effective
life-review intervention. Psychol Aging 2012, 27:1172–1181.
45. Westerhof JD, Bohlmeijer ET, van Beljouw IMJ, Pot AM: Improvement in
personal meaning mediates the effects of a life review intervention on
depressive symptoms in a randomised controlled trial. Gerontologist 2010,
50:541–549.
46. Kazantzis N, Whittington C, Dattilio F: Meta-analysis of homework effects
in cognitive and behavioral therapy: a replication and extension.
Clin Psychol Sci Pract 2010, 17:144–156.
47. Vickers AJ: How many repeated measures in repeated measures designs?
Statistical issues for comparative trials. BMC Med Res Meth 2003, 3:22.
48. Antony MM, Bieling PJ, Cox BJ, Enns MW, Swinson RP: Psychometric
properties of the 42-item and 21-item versions of the Depression
Anxiety Stress Scales (DASS) in clinical groups and a community sample.
Psychol Assess 1998, 10:176–181.
49. Mahmoud JSR, Hall LA, Staten R: The psychometric properties of the
21-item Depression, Anxiety, and Stress Scale (DASS-21) among a sample
of young adults. Southern Online J Nurs Res 2010, 10(4) [http://www.
resourcenter.net/images/snrs/files/sojnr_articles2/Vol10Num04Art02.html]
50. Steger MF, Frazier P, Oishi S, Kaler M: The meaning in life questionnaire:
assessing the presence of and search for meaning in life. J Counseling
Psychol 2006, 53:80–93.
51. Chen G, Gully SM, Eden D: Validation of a new general self-efficacy scale.
Org Res Meth 2001, 4:62–83.
52. Scherbaum CA, Cohen-Charash Y, Kern MJ: Measuring general self-efficacy:
a comparison of three measures using item response theory.
Psychol Measure 2006, 66:1047–1063.
53. Rosenberg M: Society and the Adolescent Self-Image. Princeton, NJ: Princeton
University Press; 1965.
54. Gray-Little B, Williams VS, Hancock TD: An item response theory analysis
of the Rosenberg self-esteem scale. Person Soc Psychol Bull 1997,
23:443–451.
55. Carver CS, Scheier M: Optimism. In Positive Psychological Assessment:
Handbook of Models and Measures. Edited by Lopez SJ, Sydner CR.
Washington, DC: American Psychological Association; 2003.
Hallford and Mellor Trials 2013, 14:343 Page 8 of 8
http://www.trialsjournal.com/content/14/1/34356. Harp Scates SK, Randolph DL, Gutsch KU, Knight HV: Effects of cognitive-
behavioral, reminiscence, and activity treatments on life satisfaction and
anxiety in the elderly. Int J Aging Human Develop 1986, 22:141–146.
57. Korte J, Bohlemeijer ET, Cappeliez P, Smit F, Westerhof GJ: Life review
therapy for older adults with moderate depressive symptomatology: a
pragmatic randomised controlled trial. Psychol Med 2012, 42:1163–1173.
58. Jacobson NS, Traux P: Clinical significance: a statistical approach to
defining meaningful change in psychotherapy research. J Consult Clin
Psychol 1991, 59:12–19.
59. Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ,
Elbourne D, Egger M, Altman DG: CONSORT 2010 explanation and
elaboration: updated guidelines for reporting parallel group randomised
trials. Int J Surgery 2012, 10:28–55.
60. Braun V, Clarke V: Using thematic analysis in psychology. Qual Res Psychol
2006, 3:77–101.
61. McKnight PE, Kashdan PB: The importance of functional impairment to
mental health outcomes: a case for reassessing our goals in depression
treatment research. Clin Psychol Rev 2009, 29:243–259.
62. Agüera-Ortiz L, Failde I, Mico JA, Cervilla J, López-Ibor JJ: Pain as a
symptom of depression: prevalence and clinical correlates in patients
attending psychiatric clinics. J Affect Disord 2009, 130:106–112.
63. Cuijpers P, Smit F: Excess mortality in depression: a meta-analysis of
community studies. J Affect Disord 2002, 72:227–236.
64. Luppa M, Heinrich S, Angermeyer MC, König HH, Riedel-Heller SG: Cost-of-
illness of depression: a systematic review. J Affect Disord 2007, 98:29–43.
65. Donohue JM, Pincus HA: Reducing the societal burden of depression: a
review of economic costs, quality of care, and effects of treatment.
Pharmaco Econ 2007, 25:7–24.
66. Bluck S, Alea N: Remembering being me: the self continuity function of
autobiographical memory in younger and older adults. In Self Continuity:
Individual and Collective Perspectives. Edited by Sani F. New York: Psychology
Press; 2008:55–70.
67. Bluck S, Alea N: Thinking and talking about the past: why remember?
App Cog Psychol 2009, 23:1089–1104.
doi:10.1186/1745-6215-14-343
Cite this article as: Hallford and Mellor: Cognitive-reminiscence therapy
and usual care for depression in young adults: study protocol for a
randomized controlled trial. Trials 2013 14:343.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
